On Thursday evening, the Los Angeles Lakers played the Milwaukee Bucks (at home) in California. They were playing without most of their top players and lost by ...
GOLDSBORO, N.C. (WITN) - Congressman Don Davis made a special visit to a military base in Goldsboro today. Upon touring ...
Congressman Dusty Johnson has joined a bipartisan group of lawmakers to call on Congress and the Trump administration to ...
Exclusive new testing by Consumer Reports highlights safer formulas while also identifying some that contain potentially ...
LSU star Flau'jae Johnson continues to combine her basketball and rap careers with a new Powerade commercial during March ...
A Seattle retiree was mistakenly marked as deceased by Social Security, causing his benefits to be revoked. His case, first ...
Johnson & Johnson announced that the FDA has approved TREMFYA, or guselkumab, the first and only IL-23 inhibitor ...
JNJ stock hits Golden Cross, signaling potential long-term upside. Latest breakthrough in lung cancer treatment could provide additional catalyst.
Johnson & Johnson announced that new data from its oncology pipeline will be presented at the 2025 European Lung Cancer Congress, including ...
"In reality, it puts these communities at risk." Lawsuit targets billion-dollar corporation over deceptive marketing: 'It ...
Johnson & Johnson's nipocalimab receives FDA Fast Track status for Sjögren's disease, following strong Phase 2 trial results ...
Johnson & Johnson's nipocalimab earns FDA Fast Track status for Sjögren's disease, speeding development and review for unmet medical needs.